Sarissa Capital Management LP

Sarissa Capital Management was founded by Alex Denner, Ph.D., in 2013 to capitalize on compelling opportunities for constructive shareholder activism within the healthcare sector. The fund's team of subject matter experts and its philosophy of thoughtful engagement aim to create positive outcomes for investors, shareholders, and patients by taking an owner-oriented approach to investments. Sarissa seeks to optimize healthcare companies to efficiently provide important medicines to society and enhance the impact of medical innovation, while also generating value for shareholders.

Alexander Denner

Dr. Alex Denner is the founding partner and Chief Investment Officer of Sarissa Capital Management LP, established in 2011 to enhance shareholder value through strategic improvements in companies. Previously, he was a Senior Managing Director at Icahn Capital L.P. (2006–2011) and a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner currently serves on the boards of Biogen Inc. and Ironwood Pharmaceuticals, Inc. In the past five years, he has chaired the boards of Ariad Pharmaceuticals, Inc. and The Medicines Company and served as a director of Bioverativ Inc. He holds an S.B. in Mechanical Engineering from MIT and an M.S., M.Phil., and Ph.D. in Mechanical Engineering from Yale University.

Nil

Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).